Argus Adjusts Price Target on CME Group to $245 From $235
CME Gr Analyst Ratings
Piper Sandler Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $250
Piper Sandler Keeps Their Buy Rating on CME Group (CME)
Morgan Stanley Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $236
Morgan Stanley Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $236
CME Group: Hold Rating Maintained Amid Modest EPS Adjustments and Cautious Price Target Increase
RBC Capital Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $235
BofA Securities Maintains CME Group(CME.US) With Sell Rating, Maintains Target Price $181
Oppenheimer Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $258
CME Group Price Target Raised to $258.00/Share From $245.00 by Oppenheimer
CME Group Is Maintained at Outperform by Oppenheimer
Citigroup Maintains Buy on CME Gr, Raises Price Target to $255
A Quick Look at Today's Ratings for CME Group(CME.US), With a Forecast Between $181 to $258
CME Gr Analyst Ratings
Morgan Stanley Adjusts Price Target on CME to $236 From $233
Barclays Remains a Hold on CME Group (CME)
J.P. Morgan Maintains CME Group(CME.US) With Sell Rating, Raises Target Price to $209
Morgan Stanley Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $233
Morgan Stanley Sticks to Its Hold Rating for CME Group (CME)